Welcome to the COVID-19 Page!
Cardiovascular Implications of COVID-19
Cardiovascular Implications of COVID-19
Podcast Episodes
Circulation Video Series:
COVID Updates from the Front Lines
CIRCULATION COVID Team member Carine Hamo, MD interviews Héctor Bueno, MD, PhD at the Spanish National Centre for Cardiovascular Research in Madrid about his experience dealing with the pandemic.
CIRCULATION COVID Team member Amit Goyal, MD interviews Marco Metra, MD, a researcher cardiologist at the University of Brescia, Italy, about his experience treating patients during the COVID19 pandemic.
CIRCULATION COVID Team member Daniel Ambinder, MD continues his interview with Dr. Nir Uriel, MD, a research cardiologist at Columbia University Medial Center, about how they are managing patients during the COVID pandemic.
CIRCULATION COVID Team member Daniel Ambinder, MD continues his interview with Dr. Nir Uriel, MD, a research cardiologist at Columbia University Medial Center, about how they are managing patients during the COVID pandemic.
COVID-19 Youtube Lecture Series
In this high yield review, acute respiratory distress syndrome (ARSS) and key principles of mechanical ventilation are discussed including ventilator induced lung injury, lung protective ventilation, initial ventilator settings and titration, and adjunctive therapy.
Learn more about Drs Gage, Higgins, and Lee.
Click to see JACC Publication on this topic by Dr. Gage et. al.
Dr. Pranoti Hiremath delivers a phenomenal review of the current literature and impact of COVID-19 as it pertains to the cardiovascular system from what is known as of March 19th 2020.
Dr. Richa Gupta from Vanderbilt University Medical Center discusses what is known about myocardial injury in COVID-19 patients. Myocarditis diagnosis and treatment is reviewed and a paradigm for the clinical course of late presenting COVID-19 ARDS with systemic hyperimmune injury is described.
Dr. Richa Gupta from Vanderbilt University Medical Center discusses what is known about myocardial injury in COVID-19 patients. Treatment for COVID-19 related myocarditis is discussed including supportive management as well as a pharmacologic strategies under investigation that include antiviral agents, immune-modulators, statins, and convalescent plasma.
Dr. Deepak Atri discusses the basic science behind COVID-19 with regards to the coronavirus lie cycle, molecular methods by which novel disease was linked to SARS-COV-2, the importance of angiotensin-converting enzyme 2, and molecular basis for emerging therapies (Parts 1 & 2). Drs. Victor Nauffal discusses the epidemiology, clinical characteristics, cardiovascular manifestations and outcomes, and emerging therapies for COVID-19 (Parts 3 & 4).
Dr. Deepak Atri discusses the basic science behind COVID-19 with regards to the coronavirus lie cycle, molecular methods by which novel disease was linked to SARS-COV-2, the importance of angiotensin-converting enzyme 2, and molecular basis for emerging therapies (Parts 1 & 2). Drs. Victor Nauffal discusses the epidemiology, clinical characteristics, cardiovascular manifestations and outcomes, and emerging therapies for COVID-19 (Parts 3 & 4).
Dr. Deepak Atri discusses the basic science behind COVID-19 with regards to the coronavirus lie cycle, molecular methods by which novel disease was linked to SARS-COV-2, the importance of angiotensin-converting enzyme 2, and molecular basis for emerging therapies (Parts 1 & 2). Drs. Victor Nauffal discusses the epidemiology, clinical characteristics, cardiovascular manifestations and outcomes, and emerging therapies for COVID-19 (Parts 3 & 4).
Dr. Deepak Atri discusses the basic science behind COVID-19 with regards to the coronavirus lie cycle, molecular methods by which novel disease was linked to SARS-COV-2, the importance of angiotensin-converting enzyme 2, and molecular basis for emerging therapies (Parts 1 & 2). Drs. Victor Nauffal discusses the epidemiology, clinical characteristics, cardiovascular manifestations and outcomes, and emerging therapies for COVID-19 (Parts 3 & 4).
COVID-19 pathophysiology, oxygenation failure with progression to ARDS, organ dysfunction, basic ECMO understanding and literature is reviewed. ECMO criteria for COVID-19 is discussed along with basic VV-ECMO management and trouble shooting tips and tricks.
Sergio B. Navarrete, DO is currently an Anesthesiology & Critical Care Medicine Critical Care Fellow at the Johns Hopkins University.
COVID-19 #Tweetorials
1/21 After caring for patients in the ICU with #COVID for the last week, the time seems right for a #pulmonology #tweetorial on #Proning or #PronePositioning @sanjayvdesai @OslerResidency @JHUPCCMFellows @CPSolvers @thecurbsiders @cardionerds @tony_breu @david_furfaro @chadhoc pic.twitter.com/n9lOetBu5j
— Bryan Broderick, MD (@BBroderickMD) March 30, 2020
Tweetorial of heart-lung interactions in the setting of mechanical ventilation (MCV) from @cardionerds episode 20. https://t.co/RdHbYA5QfH
— Sam Brusca (@Sam_Brusca) March 22, 2020
These concepts will apply to critically ill COVID-19 patients that are developing concurrent respiratory and cardiac failure.
1/10
1/ A few thoughts after a few days in the ICU with #COVID19
— David Furfaro (@david_furfaro) March 20, 2020
*Pt care: As has been reported, (some) pts w/ covid have severe hypoxemia without markedly stiff lungs. Can greatly increase PEEP, decrease Vt -> improve oxygenation, and maintain low driving and plateau pressures
1/ ❤️🤓 Time to reacquant yourselves for ARDS management!
— Amit Goyal (@AmitGoyalMD) March 31, 2020
Here is a @cardionerds #tweetorial review of this phenomenal lecture:
🔥On ARDS in #COVID19 🔥
By @AnnGageMD, @RanLeeMD & @AndrewHigginsMD
Video: https://t.co/uDJArWH1PS
Article: https://t.co/TG36boJuVl pic.twitter.com/8gVlU8184D
1/18
— Saman Nematollahi (@TxID_Edu) April 1, 2020
Going along with @cardionerds Part 1 of 4 (Episode 24), here’s some info regarding #COVID19 treatmenthttps://t.co/cW5G97zYK9 pic.twitter.com/j5DSmuvRre